Grab, A. L., Kim, P. S., John, L., Bisht, K., Wang, H., Baumann, A., . . . Raab, M. (2024). Pre-clinical assessment of SAR442257, a CD38/CD3xCD28 trispecific T cell engager in treatment of relapsed/refractory multiple myeloma. Cells, 13(10), . https://doi.org/10.3390/cells13100879
Chicago-Zitierstil (17. Ausg.)Grab, Anna Luise, et al. "Pre-clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/refractory Multiple Myeloma." Cells 13, no. 10 (2024). https://doi.org/10.3390/cells13100879.
MLA-Zitierstil (9. Ausg.)Grab, Anna Luise, et al. "Pre-clinical Assessment of SAR442257, a CD38/CD3xCD28 Trispecific T Cell Engager in Treatment of Relapsed/refractory Multiple Myeloma." Cells, vol. 13, no. 10, 2024, https://doi.org/10.3390/cells13100879.